Click on image to view ad details and full-size version on AdPharm

To see all of this brand’s ads on AdPharm, click here

For adults with chronic moderate to severe plaque psoriasis
Clearer skin in 3 months

Before Enbrel. An example of one skin area. After Enbrel. Your results may vary.
Example of approximately 75% skin clearance.

If you and your doctor decide that Enbrel is right for you, ask about the Enbrel support co-pay program.
No co-pay for 6 months for eligible patients.

Ask your dermatologist if Enbrel is right for you. Learn more: visit enbrel.com or call 1-888-4ENBREL.

Brand name: Enbrel
Generic name/category: Etanercept, TNF inhibitor
Company: Amgen and Wyeth
Country/Market: USA, North America
Indication(s)/use: Moderate to severe chronic plaque psoriasis (PsA)
Target: Consumers (DTC)
Publication: People Magazine June 15 2009

To see all of this brand’s ads, click here

Here are two Enbrel ads both published in the May edition of Dermatology Times.

Thanks, Doc. Thank you!
For the treatment of moderate to severe plaque psoriasis
Your confidence is built patient by patient

Enbrel is the #1 most prescribed biologic in dermatology offices for psoriatic diseases

Enbrel binds reversibly to TNF

Enbrel continuously binds and unbinds to TNF.

When bound to TNF, Enbrel inhibits TNF activity.
When released, TNF continues its normal function in the immune system.

Brand name: Enbrel
Generic name/category: Etanercept, TNF inhibitor
Company: Amgen and Wyeth
Country/Market: USA, North America
Indication(s)/use: Moderate to severe plaque psoriasis
Target: Healthcare Professionals (HCP)
Tagline: Trust your experience
Publication: Dermatology Times May 2009